NF-κB and GATA-Binding Factor 6 Repress Transcription of Caveolins in Bladder Smooth Muscle Hypertrophy

Area of Science:

• Molecular Biology
• Cell Biology
• Urology

Background:

• Caveolins (CAVs) are crucial for smooth muscle contraction and signaling.
• Loss of CAVs impairs bladder smooth muscle (BSM) contraction in hypertrophy.
• Obstructive bladder diseases are linked to reduced CAV protein expression.

Purpose of the Study:

• Investigate the mechanisms regulating CAV1, CAV2, and CAV3 gene expression in BSM.
• Identify transcription factors involved in CAV gene repression in obstructive bladder disease.
• Characterize regulatory regions controlling CAV gene transcription in BSM.

Main Methods:

• Microarray analysis of bladder RNA from mouse and human models.
• DNA affinity chromatography and chromatin immunoprecipitation assays.
• Gene manipulation (knockout, knockdown, overexpression) and pharmacologic inhibition of transcription factors.

Main Results:

• CAV1, CAV2, and CAV3 gene transcription is down-regulated in obstructed BSM.
• GATA-binding factor 6 (GATA-6) and NF-κB binding increases on CAV promoters in obstructed BSM.
• Inhibition of GATA-6 and NF-κB enhances CAV gene transcription and promoter activity, while GATA-6 overexpression represses it.

Conclusions:

• GATA-6 and NF-κB are key repressors of CAV gene expression in hypertrophied BSM.
• Understanding these regulatory mechanisms offers therapeutic targets for obstructive bladder diseases.
• This study elucidates novel insights into CAV gene regulation in BSM pathophysiology.